These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1952 related articles for article (PubMed ID: 11441937)

  • 1. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
    Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
    Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
    Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
    J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
    Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
    Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
    Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
    J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
    Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic overview of chemotherapy effects in gastric cancer.
    Janunger KG; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
    Nordlinger B; Rougier P; Arnaud JP; Debois M; Wils J; Ollier JC; Grobost O; Lasser P; Wals J; Lacourt J; Seitz JF; Guimares dos Santos J; Bleiberg H; Mackiewickz R; Conroy T; Bouché O; Morin T; Baila L; van Cutsem E; Bedenne L
    Lancet Oncol; 2005 Jul; 6(7):459-68. PubMed ID: 15992694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.
    Chrisp P; McTavish D
    Drugs Aging; 1991; 1(4):317-37. PubMed ID: 1794023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for colorectal cancer.
    Goyle S; Maraveyas A
    Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer. TTD Spanish Cooperative Group.
    Sastre J; Navarro M; Aranda E; Fonseca E; Checa T; Alonso MC; Gallen M; Camps C; Antón A; Díaz-Rubio E
    Oncol Rep; 1999; 6(6):1421-4. PubMed ID: 10523723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
    Wolmark N; Colangelo L; Wieand S
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):9-13. PubMed ID: 11273592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.